U.S. markets open in 7 hours 10 minutes
  • S&P Futures

    3,928.25
    +30.50 (+0.78%)
     
  • Dow Futures

    31,391.00
    +189.00 (+0.61%)
     
  • Nasdaq Futures

    12,013.00
    +134.75 (+1.13%)
     
  • Russell 2000 Futures

    1,793.00
    +18.10 (+1.02%)
     
  • Crude Oil

    110.85
    -1.36 (-1.21%)
     
  • Gold

    1,845.50
    +4.30 (+0.23%)
     
  • Silver

    22.05
    +0.14 (+0.65%)
     
  • EUR/USD

    1.0588
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    2.8550
    0.0000 (0.00%)
     
  • Vix

    29.35
    -1.61 (-5.20%)
     
  • GBP/USD

    1.2490
    +0.0015 (+0.12%)
     
  • USD/JPY

    127.9290
    +0.1350 (+0.11%)
     
  • BTC-USD

    30,072.48
    +887.33 (+3.04%)
     
  • CMC Crypto 200

    670.85
    +18.62 (+2.85%)
     
  • FTSE 100

    7,302.74
    -135.35 (-1.82%)
     
  • Nikkei 225

    26,739.03
    +336.19 (+1.27%)
     

FDA Approves TherapeuticsMD's Low Dose Bijuva

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

TherapeuticsMD Inc (NASDAQ: TXMD) is trading sharply higher after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women with vasomotor symptoms due to menopause.

See more from Benzinga

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.